Please assess the completion status of the following clinical trial:

Trial Title: A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~Female patients who meet the following criteria:~1. Patients satisfying the Rome III Diagnostic Criteria~2. Patients whose ≥25% of stools were loose or watery and \<25% of them were hard or lumpy stools~3. Patients who have abdominal pain or discomfort~4. Patients in whom after occurrence of IBS symptoms the following tests were conducted and in whom no organic changes were observed Pancolonoscopy or contrast enema~Exclusion Criteria:~Patients who meet any of the following criteria:~1. Patients with a history of surgical resection of the stomach,gallbladder, small intestine or large intestine~2. Patients with a history or current evidence of inflammatory bowel disease~3. Patients with a history or current evidence of colitis ischemic~4. Patients with concurrent infectious enteritis~5. Patients with concurrent hyperthyroidism or hypothyroidism~6. Patients with concurrent active peptic ulcer~7. Patients with other concurrent disease that may affect the digestive tract passage or large intestinal function or that is likely to interfere with proper assessment of IBS abdominal pain/discomfort

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- Female Patients with D-IBS (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).